Genentech Company Updates | Glassdoor.com.au

Company Updates

  • We're excited to welcome Aviv Regev, Ph.D., our new head of Research and Early Development, whose research on single-cell genomics paved the way for understanding disease on a cellular level. Learn more about our scientists and their groundbreaking research.

  • We're investing in technology today that will transform personalized healthcare in the future. Dr. Mark Lee, our Global Head of Personalized Healthcare Product Development, recently shared with POLITICO how Genentech is leveraging data to deliver a new era of personalized healthcare. Learn how we're working to deliver this next generation of the best possible care for patients.

  • COVID-19

    COVID-19 has necessitated new ways of working to ensure that the important work of discovering and delivering critical medicines continues despite the new complexities. Nancy Oaks, Head of Customer Engagement, and Jamie Freedman, Head of U.S. Medical Affairs share how our teams have adapted their ways of working, leveraged our new customer engagement model, and found innovative ways to deliver on our mission during the pandemic.

  • We strive to improve the health and wellbeing of all patients, and create a future of science that is more diverse, inclusive and equitable. We're announcing two new charitable funding opportunities. The two funds will focus on forging partnerships that tackle systemic inequalities across healthcare and education: (1) The Health Equity Innovations Fund will support efforts that address healthcare disparities for historically underserved communities, with a focus on advancing inclusive research and promoting equity in care. (2) The Diverse Future of STEM Fund will solicit grant proposals to help increase racial and ethnic diversity in the healthcare and biomedical research community through K-12, undergraduate and post-secondary learning opportunities. Learn more about our grantmaking programs and applying for funding below.

  • With all of our interns onboard for the summer, we?re thrilled to see the meaningful projects they'll work on! To spark up some fun, we kicked off a House Cup as a means for our interns to interact and foster a sense of community throughout the summer. Last month, a secret message revealed our house teams. Best of luck on your friendly challenges Genentech Interns! Learn more about our university and early career programs here.

  • We've been named on Insider Pro and Computerworld's list of the Best Places to Work in IT for the 12th year in a row and ranked number 1 in benefits! Our IT team is critical to driving the innovative and meaningful initiatives that aim to create a better future for patients. Read the full list below and if you're interested in joining our IT team, view some of our IT careers here: https://bit.ly/2VbNzEM.

  • This week marks our 10th anniversary of Genentech Gives Back— a special week of employee volunteerism and fundraising. While we're coming together virtually this year, our passion for giving in service of science, patients, and people remains just as strong. At a time when COVID-19 is exacerbating existing economic and healthcare disparities and events of the past weeks have cast a spotlight on racial injustice and inequity in our country, the needs of our communities have never been greater. We’re proud of our employees as they come together virtually to make a difference, and we're grateful to our partner organizations for working tirelessly to drive much-needed change.

  • Earlier this month, our CEO shared our stance on inequity and injustice. Now more than ever is the time to embrace allyship within and beyond our organizations. We stand with the Black community against racial discrimination, violence, and injustice. And we commit to speaking up and taking action to advance equity. Read the statement from our CEO here:

  • COVID-19

    Doing our part during the COVID-19 crisis means going beyond our vital day-to-day work to advance science. We’re committing $42 million to provide immediate and long-term support to our communities, including low-income households and people of color disproportionately impacted by the pandemic. This support includes emergency response grants as well as funds for longer-term recovery efforts to mitigate ongoing challenges posed by the breadth and depth of this health crisis. Learn more about the three principles that have guided our approach to giving from Kristin Campbell Reed, our Senior Director of Corporate and Employee Giving.

  • COVID-19

    We take the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. Learn more here:

Work at Genentech? Share Your Experiences

Genentech
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or